Followers | 2543 |
Posts | 250754 |
Boards Moderated | 35 |
Alias Born | 05/06/2014 |
Thursday, November 20, 2014 1:54:24 PM
Are you suggesting there are no shorties on $NVLX? I can prove to you that there is a significant failure to deliver. Here is the official # from the SEC for Nov 2014. There is delivery failure on the remaining. They will attempt to cover every day this week and last week so be prepared to squeeze them hard by not hitting bids!
Take a look at the data, straight from the SEC:
Historical Short Selling Data For NVLX
Nov 19 41.58% 0.24 0.21 0.23 689,293 1,657,596
Nov 18 8.98% 0.21 0.20 0.20 89,671 998,191
Nov 17 19.07% 0.23 0.20 0.21 185,605 973,233
Nov 14 24.34% 0.23 0.22 0.22 256,304 1,052,997
Nov 13 18.85% 0.24 0.22 0.23 167,680 889,516
Nov 12 11.80% 0.24 0.23 0.24 143,319 1,214,537
Nov 11 16.74% 0.25 0.24 0.24 96,484 576,520
Nov 10 34.69% 0.25 0.24 0.25 322,332 929,138
Nov 07 42.66% 0.25 0.24 0.25 527,412 1,236,187
Nov 06 21.16% 0.24 0.23 0.24 159,150 752,216
Nov 05 19.78% 0.25 0.23 0.23 208,677 1,055,113
Nov 04 24.34% 0.26 0.24 0.24 250,393 1,028,855
Nov 03 47.04% 0.26 0.22 0.25 1,128,306 2,398,496
http://www.sec.gov/foia/docs/failsdata.htm#.U_DnxvldVhw
http://otcshortreport.com/index.php?index=nvlx&action=view#.VG44L5PF89A
Peeps think I'm making stuff up about trapping shorties when there is solid proof. LOL
Enjoy and don't let them cover.
$NVLX
Pistol Pete!
"Patience, persistence and perspiration make an unbeatable combination for success."
Recent PMCB News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:04 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/30/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/21/2023 09:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/18/2023 10:04:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 09:00:03 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2023 01:56:25 AM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM